Dimensional Fund Advisors LP Biotechnology

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ORMP Oramed Pharmaceuticals Inc.	$83.1M	$375,000 0.0% of portfolio	166,899	Q2 2025 Added 18.3%
ELDN Eledon Pharmaceuticals, Inc.	$35.2M	$369,000 0.0% of portfolio	136,456	Q2 2025 Added 17.46%
PLRX Pliant Therapeutics, Inc.	$81.8M	$366,000 0.0% of portfolio	315,887	Q2 2025 Reduced 38.27%
CELC Celcuity Inc.	$783M	$328,000 0.0% of portfolio	24,572	Q2 2025 New
CVAC Cure Vac N.V.	$1.01B	$269,000 0.0% of portfolio	49,607	Q1 2025 New
TARA Protara Therapeutics, Inc.	$35.5M	$258,000 0.0% of portfolio	85,303	Q2 2025 Added 22.56%
SRRK Scholar Rock Holding Corp	$1.77B	$252,000 0.0% of portfolio	7,128	Q2 2025 Added 4.23%
XBIT X Biotech Inc.	$97.4M	$210,000 0.0% of portfolio	70,965	Q2 2025 Reduced 3.48%
FDMT 4 D Molecular Therapeutics, Inc.	$202M	$207,000 0.0% of portfolio	55,937	Q2 2025 Reduced 24.98%
TCRX T Scan Therapeutics, Inc.	$34.1M	$188,000 0.0% of portfolio	129,856	Q2 2025 Reduced 51.92%
CRDF Cardiff Oncology, Inc.	$89.3M	$175,000 0.0% of portfolio	55,698	Q1 2025 Reduced 18.66%
RXRX Recursion Pharmaceuticals, Inc.	$841M	$172,000 0.0% of portfolio	34,053	Q2 2025 Reduced 98.02%
CSBR Champions Oncology, Inc.	$91.8M	$165,000 0.0% of portfolio	22,405	Q2 2025 New
IMAB I Mab	$363M	$141,000 0.0% of portfolio	58,358	Q2 2024 Reduced 3.39%
LTRN Lantern Pharma Inc.	$43.5M	$129,000 0.0% of portfolio	40,940	Q2 2025 Added 9.22%
HLVX Hille Vax, Inc.	$69.5M	$122,000 0.0% of portfolio	61,542	Q1 2025 Reduced 0.65%
AADI Aadi Bioscience, Inc.	$35.9M	$120,000 0.0% of portfolio	70,749	Q2 2025 Reduced 34.2%
LRMR Larimar Therapeutics, Inc.	$164M	$90,000 0.0% of portfolio	31,354	Q2 2025 Reduced 56.84%
MNOV Medicinova Inc	$64.3M	$86,000 0.0% of portfolio	66,215	Q4 2024 Added 8.04%
DMAC Dia Medica Therapeutics Inc.	$144M	$75,000 0.0% of portfolio	19,339	Q4 2024 Added 14.03%
IMMP Immutep LTD	$143M	$74,000 0.0% of portfolio	45,167	Q2 2025 Reduced 0.71%
PLX Protalix Bio Therapeutics, Inc.	$82.1M	$67,000 0.0% of portfolio	45,571	Q2 2025 New
BMEA Biomea Fusion, Inc.	$59.5M	$63,000 0.0% of portfolio	35,411	Q2 2025 Reduced 40.29%
INMB Inmune Bio, Inc.	$37M	$58,000 0.0% of portfolio	25,139	Q4 2024 Added 71.62%
AIKI A Ikido Pharma Inc.	$20.8M	$55,000 0.0% of portfolio	14,612	Q1 2025 Reduced 63.32%
IKNA Ikena Oncology, Inc.	$50M	$51,000 0.0% of portfolio	38,621	Q1 2024 Reduced 0.03%
ABOS Acumen Pharmaceuticals, Inc.	$57.1M	$50,000 0.0% of portfolio	43,524	Q1 2025 Reduced 55.6%
ATNM Actinium Pharmaceuticals, Inc.	$43.8M	$48,000 0.0% of portfolio	34,923	Q4 2024 Reduced 31.9%
IMRX Immuneering Corp	$159M	$45,000 0.0% of portfolio	13,366	Q2 2024 Reduced 57.36%
PEPG Pep Gen Inc.	$28.4M	$44,000 0.0% of portfolio	39,699	Q2 2025 Reduced 27.33%
TNYA Tenaya Therapeutics, Inc.	$45.5M	$44,000 0.0% of portfolio	73,408	Q1 2025 Reduced 25.08%
PYXS Pyxis Oncology, Inc.	$45.3M	$40,000 0.0% of portfolio	36,516	Q1 2025 Reduced 67.12%
LCTX Lineage Cell Therapeutics, Inc.	$207M	$36,000 0.0% of portfolio	40,449	Q1 2023 Reduced 16.54%
ACET Adicet Bio, Inc.	$29.2M	$34,000 0.0% of portfolio	57,268	Q2 2025 Reduced 61.26%
VXRT Vaxart, Inc.	$48.1M	$33,000 0.0% of portfolio	75,491	Q2 2024 Reduced 3.0%
PDSB Pds Biotechnology Corp	$35.9M	$24,000 0.0% of portfolio	18,382	Q1 2025 Reduced 0.04%
PMCB Pharma Cyte Biotech, Inc.	$19.9M	$22,000 0.0% of portfolio	20,299	Q1 2025 Reduced 24.37%
PMVP Pmv Pharmaceuticals, Inc.	$68M	$17,000 0.0% of portfolio	16,210	Q2 2025 Reduced 87.14%
IMUX Immunic, Inc.	$25.7M	$9,000 0.0% of portfolio	13,151	Q2 2025 Reduced 52.21%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	180,492	Q2 2025 Reduced 3.81%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.